American Journal of Clinical Nutrition, Vol 67, 1029S-1034S, Copyright © 1998 by The American Society for Clinical Nutrition, Inc

REVIEW ARTICLES

Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency

SG Kaler
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1424, USA. sgk@box-s.nih.gov

In the 25 y since copper deficiency was first delineated in persons with Menkes syndrome, advances in our understanding of the clinical, biochemical, and molecular aspects of this rare disorder have surpassed progress in the design of effective therapies. In contrast with purely nutritional copper deficiency, in which copper replacement can be curative, the nature of the basic defect in Menkes syndrome suggests that corrective efforts are likely to be more complicated, a point supported by the cumulative literature on this topic as well as by emerging molecular data. In this paper, certain clinical, biochemical, and molecular aspects of copper histidine treatment in 25 Menkes syndrome patients at the National Institutes of Health are reviewed. The delineation of a distinctive neurochemical pattern in plasma and cerebrospinal fluid, reflecting deficiency of the copper enzyme dopamine beta-monooxygenase, is arguably the most important finding in the study of Menkes syndrome. This abnormal pattern has proven extremely reliable as a rapid diagnostic test, enabling early identification of affected infants--a fundamental requirement for improving clinical outcomes. Of 11 patients identified by prenatal or prompt postnatal testing and treated within the first 10 d of age, one walked at 14 mo of age and has normal neurodevelopment at age 3 y and another infant's early progress appears promising. However, five patients died in infancy and neurodevelopmental outcome was suboptimal in four others. Consideration of additional therapeutic strategies seems necessary, therefore, for most patients and families facing this troublesome form of copper deficiency.

This article has been cited by other articles:

				A. REYNOLDS Shaken Baby Syndrome: Diagnosis and Treatment Radiol. Technol., November 1, 2008; 80(2): 151 - 170. [Abstract] [Full Text] [PDF]

				W. I. Vonk, C. Wijmenga, and B. van de Sluis Relevance of animal models for understanding mammalian copper homeostasis Am. J. Clinical Nutrition, September 1, 2008; 88(3): 840S - 845S. [Abstract] [Full Text] [PDF]

				S. P. Nations, P. J. Boyer, L. A. Love, M. F. Burritt, J. A. Butz, G. I. Wolfe, L. S. Hynan, J. Reisch, and J. R. Trivedi Denture cream: An unusual source of excess zinc, leading to hypocupremia and neurologic disease Neurology, August 26, 2008; 71(9): 639 - 643. [Abstract] [Full Text] [PDF]

				D. Sinani, D. J. Adle, H. Kim, and J. Lee Distinct Mechanisms for Ctr1-mediated Copper and Cisplatin Transport J. Biol. Chem., September 14, 2007; 282(37): 26775 - 26785. [Abstract] [Full Text] [PDF]

				S. Lutsenko, N. L. Barnes, M. Y. Bartee, and O. Y. Dmitriev Function and Regulation of Human Copper-Transporting ATPases Physiol Rev, July 1, 2007; 87(3): 1011 - 1046. [Abstract] [Full Text] [PDF]

				L. Nyasae, R. Bustos, L. Braiterman, B. Eipper, and A. Hubbard Dynamics of endogenous ATP7A (Menkes protein) in intestinal epithelial cells: copper-dependent redistribution between two intracellular sites Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1181 - G1194. [Abstract] [Full Text] [PDF]

				B.-E. Kim, K. Smith, C. K. Meagher, and M. J. Petris A Conditional Mutation Affecting Localization of the Menkes Disease Copper ATPase. SUPPRESSION BY COPPER SUPPLEMENTATION J. Biol. Chem., November 8, 2002; 277(46): 44079 - 44084. [Abstract] [Full Text] [PDF]

				M. Jaksch, C. Paret, R. Stucka, N. Horn, J. Muller-Hocker, R. Horvath, N. Trepesch, G. Stecker, P. Freisinger, C. Thirion, et al. Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copper-binding protein, is rescued by copper in human myoblasts Hum. Mol. Genet., December 1, 2001; 10(26): 3025 - 3035. [Abstract] [Full Text] [PDF]

				M. Jaksch, I. Ogilvie, J. Yao, G. Kortenhaus, H.-G. Bresser, K.-D. Gerbitz, and E. A. Shoubridge Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency Hum. Mol. Genet., March 22, 2000; 9(5): 795 - 801. [Abstract] [Full Text] [PDF]